SELLAS Life Sciences Group, Inc. (SLS) Tops Q1 EPS by 4c

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) reported Q1 EPS of ($0.07), $0.04 better than the analyst estimate of ($0.11).

For earnings history and earnings-related data on SELLAS Life Sciences Group, Inc. (SLS) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Worthington Industries (WOR) Misses Q4 EPS by 9c
• Leerink Starts Quince Therapeutics Inc. (QNCX) at Outperform